Single use Bioprocessing Market

The report "Single Use Bioprocessing Market by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global Forecast to 2029", is projected to reach USD 34.9 billion by 2029 from USD 17.7 billion in 2024, at a CAGR of 14.5% during the forecast period of 2024 to 2029.  Some factors contributing to the growth of the global market include growing adoption among CDMOs & CMOs, increased productivity & reduced risk of cross-contamination, reduced capital investment, and growing biologics & biosimilar markets. Despite this, concerns related to regulatory compliance, and leachables & extractables issues are expected to hinder market growth.

Browse 739 market data Tables and 61 Figures spread through 565 Pages and in-depth TOC on "Single Use Bioprocessing Market by Product (Equipment (Bioreactors, Mixers, Filtration, Chromatography), Consumables (Filters, Bags, Assemblies, Sensors)), Application, Workflow, Molecule Type (mAbs, Vaccines, CGT, Peptides) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html

The single-use bioreactors segment accounted for the largest share of the equipment segment in the single-use bioprocessing market in 2023.

Based on equipment type, the single-use bioprocessing market is segmented into single-use bioreactors, single-use mixing systems, single-use filtration system, single-use chromatography systems, and other single-use systems. Single-use bioreactors (SUBs) segment dominated the market in 2023 and is expected to dominate the market in the forecast period. SUBs have emerged as a pivotal technology within the single-use bioprocessing market, revolutionizing the way biopharmaceutical products are developed and manufactured. They offer a range of advantages over traditional stainless-steel bioreactors, making them highly attractive to biopharmaceutical companies, contract manufacturing organizations (CMOs), and research institutions.

The cell culture segment is estimated to register the highest growth rate during the forecast period in the single-use bioprocessing market.

Based on application, the single-use bioprocessing market is further segmented into cell culture, filtration, purification, mixing, storage & transfer, and other applications. Cell-culture procedures are carried out in upstream processes. Single-use bioprocessing (SUB) has revolutionized cell culture applications in the biopharmaceutical industry, offering unparalleled flexibility, cost efficiency, and reduced contamination risks.

The Asia Pacific region will be the fastest-growing region of the single-use bioprocessing market in 2023.

Based on the region, the single-use bioprocessing market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia Pacific is anticipated to register fastest growth in the single-use bioprocessing owing to the increasing demand for biosimilars, significant investments by biopharmaceutical companies & CMOs in emerging Asia Pacific countries, and increasing focus on developing advanced healthcare products.

Key players in the single-use bioprocessing market include Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), 3M Company (US), Repligen Corporation (US), Entegris (US), Getinge AB (Sweden), Parker Hannifin Corporation (US), Alfa Laval Corporate AB (Sweden), Saint-Gobain (France), Eppendorf SE (Germany), Corning Incorporated (US), Eaton Corporation plc (Ireland), METTLER TOLEDO (US), Porvair PLC (UK), Lonza (Switzerland), ABEC, INC. (US), NewAge Industries (US), PBS Biotech, Inc. (US), Sentinel Process Systems, Inc. (US), Meissner Filtration Products, Inc. (US), SATAKE MultiMix Corporation (Japan), Hamilton Company (US), Membrane Solutions (US), Cole-Parmer Instrument Company, LLC (US), Distek, Inc. (US), Esco Lifesciences Group Ltd. (US), and TECNIC Bioprocess solutions (Spain).

Don’t miss out on business opportunities in Single Use Bioprocessing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]